SPYRE THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 2254000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | SPYRE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:49:38.245373+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/30e2a886-d5d4-4787-b820-98da01d06740
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-014021 · Open the official SEC filing →Retrieved: 2026-08-19T16:49:38.245373+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001636282/accounts-payable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/30e2a886-d5d4-4787-b820-98da01d06740
History
- no predecessors — first report